Cargando…
MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma
Anthracycline-based chemotherapy resistance represents a major challenge in diffuse large B-cell lymphoma (DLBCL). MiRNA and gene expression profiles (n = 47) were determined to uncover potential chemoresistance mechanisms and therapeutic approaches. An independent correlation between high expressio...
Autores principales: | Zhou, Wenping, Xu, Yuanlin, Zhang, Jiuyang, Zhang, Peipei, Yao, Zhihua, Yan, Zheng, Wang, Haiying, Chu, Junfeng, Yao, Shuna, Zhao, Shuang, Yang, Shujun, Guo, Yongjun, Miao, Jinxin, Liu, Kangdong, Chan, Wing C., Xia, Qingxin, Liu, Yanyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252898/ https://www.ncbi.nlm.nih.gov/pubmed/35488020 http://dx.doi.org/10.1038/s41375-022-01565-6 |
Ejemplares similares
-
A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression
por: Ma, Jialin, et al.
Publicado: (2020) -
Decitabine-containing G-CSF priming regimen overcomes resistance of primary mediastinal neoplasm from early T-cell precursors to conventional chemotherapy: a case report
por: Yang, Yuhuan, et al.
Publicado: (2019) -
Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options
por: Yao, Shuna, et al.
Publicado: (2017) -
The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9
por: Xu, Yuanlin, et al.
Publicado: (2018) -
Anti-Angiogenic Agent Combined with Anti-PD-1 Immunotherapy Showed Activity in Patients With Classical Hodgkin Lymphoma Who Have Failed Immunotherapy: A Retrospective Case Report Study
por: Yan, Zheng, et al.
Publicado: (2021)